 |
0 Diseases |  |
1 Trial |
|
1 Trial |  |
12 News |  |
- | Journal: Drugs for chronic insomnia. (Pubmed Central) - Jan 12, 2023
No abstract available
- | Journal: Expanded table: Some oral drugs for chronic insomnia. (Pubmed Central) - Jan 12, 2023
No abstract available No abstract available
- | Quviviq (daridorexant) / Idorsia, Mochida, Syneos Health
Journal: Daridorexant (Quviviq) for insomnia. (Pubmed Central) - Jul 16, 2022
No abstract available No abstract available
- |||||||||| zolpidem sublingual / Generic mfg.
New P3 trial: Safety and Efficacy of Zolpidem in the Long-Term Treatment of Insomnia (clinicaltrials.gov) - Jul 13, 2022
P3, N=358, Not yet recruiting, Sponsor: EMS
- zolpidem sublingual / Generic mfg.
[VIRTUAL] Lipidome signatures of higher BMI and systemic inflammation in pregnant African American women () - Jul 23, 2021 - Abstract #Fertility2021Fertility_91;
Higher levels of lipid species diglyceride(DG) DG(40:5), phosphatidylcholine(PC) PC 16:0, PC(O-47:2), PC(Ox26:0), triglyceride(TG) TG(49:1) TG(49:2), TG(55:6), TG(57:9), TG(64:7), and TG(66:9) were associated with the higher BMI group, whereas PC(O-37:3), PC(Ox22:00), fatty acid(FA) FA23:3, FA23:4, phosphatidylethanolamine(PE) PE(20:0), and PE(30:0) were associated with the lower BMI group... Maternal BMI and inflammatory markers are related to lipidomic profiles and detailed investigation of these markers may lead to identification of the metabolic pathways associated with higher BMI and systemic inflammation among pregnant African American women.
- || Edluar (zolpidem) / Mylan, Stilnox (zolpidem) / Sanofi
Eszopiclone (#Lunesta), #zaleplon (#Sonata) and #zolpidem (#Ambien, Ambien CR, #Edluar, Intermezzo and #Zolpimist) will require the new FDA boxed warnings about unsafe behavior like sleepwalking, sleep-driving and other complex behaviors while sleeping. https://t.co/CAplYeY3R4 (Twitter) - May 1, 2019
- ||| zolpidem sublingual / Generic mfg.
Enrollment closed: Efficacy and Safety of 5 mg Sublingual Zolpidem vs 10mg Oral Zolpidem in the Induction and Maintenance of Sleep in Patients With Primary Insomnia (clinicaltrials.gov) - Sep 22, 2013
P4, N=60, Active, not recruiting, Sponsor: EMS
Maternal BMI and inflammatory markers are related to lipidomic profiles and detailed investigation of these markers may lead to identification of the metabolic pathways associated with higher BMI and systemic inflammation among pregnant African American women. Recruiting --> Active, not recruiting
- ||||| zolpidem sublingual / Generic mfg.
New P4 trial: Efficacy and Safety of 5 mg Sublingual Zolpidem vs 10mg Oral Zolpidem in the Induction and Maintenance of Sleep in Patients With Primary Insomnia (clinicaltrials.gov) - Jul 9, 2013
P4, N=60, Active, not recruiting, Sponsor: EMS